A 2.5 mg vardenafil start still needs a QT look

01Small milligrams do not retire the QT sentence

Levitra labeling tells clinicians to avoid vardenafil in congenital QT prolongation and in patients on Class IA or Class III antiarrhythmics. The sentence does not say "except 2.5 mg." Halo's locked 2.5 mg start is still vardenafil.

A dedicated QT study in 59 healthy men aged 45-60 compared therapeutic 10 mg and supratherapeutic 80 mg with moxifloxacin 400 mg. At one hour - near Tmax - Fridericia-corrected QTc rose about 8 msec on 10 mg, 10 msec on 80 mg, and 8 msec on moxifloxacin, versus placebo. Heart rate rose about 5-6 beats per minute. The study was not built for pairwise superiority claims. Clinical impact of those millisecond shifts is unknown.

Unknown is not the same as none. It is why the avoid list exists. Do not talk patients out of the warning because 2.5 mg "sounds tiny." A small start is still a QT-active start, and the avoid list does not shrink with the milligrams.

02What a screen looks like on a busy Montreal visit

• Write the antiarrhythmic names, not "heart pills"
• Ask congenital long QT in the patient's words
• Do not use 2.5 mg to dodge an avoid-list drug
• If vardenafil is blocked, do not stack a second PDE5 at home

Start with the list, not the ECG machine. Name every antiarrhythmic, every "heart rhythm pill," and every inherited-QT story in the family. Patients say "a blood-pressure pill" when they mean sotalol. Ask again.

If the list is dirty, stop. Offer sildenafil or tadalafil only after a clinician who owns the arrhythmia file agrees those are acceptable. Class PDE5 drugs are not identical on QT language. Vardenafil's warning is the loud one.

If the list is clean and the history is quiet, some clinicians still want a recent ECG before any PDE5 in a man with syncope, unexplained seizures, or a family sudden-death story. This note does not order that ECG. It says do not skip the question because the tablet is 2.5 mg.

Nitrates remain a hard stop for the whole class. A clean QT screen does not legalize nitroglycerin. Chest pain after vardenafil still goes to EMS with the drug name. Nitrate wait after vardenafil 20 mg in the label's NTG work was 24 hours before extra pressure effects were gone.

03This is not a QTc calculator

We will not invent a home QTc cutoff or a phone-app clearance. Fridericia versus individual correction already disagreed by a few milliseconds in the 59-man study. No single correction is known to be more valid. Do not pick a number from a forum and call it a screen.

Men already followed in a long-QT clinic should hear vardenafil from that clinic, not from an ED title. Men on amiodarone for atrial fibrillation should hear it from the prescriber who owns the amiodarone, not from a leftover 2.5 mg sample.

Onset questions - how fast, food, ODT versus film - belong in onset notes. Do not let a fast-onset pitch skip the QT paragraph.

04When the screen says no

A blocked vardenafil plan is a completed screen, not a failure. The contrast sheet exists so the next molecule is a choice, not a random blister. Tadalafil daily 2.5 mg and sildenafil 100 mg are Halo locks on their own pages. They still need nitrate checks.

Do not "try a tiny vardenafil anyway" because the avoid-list drug is taken only at night. Class IA and III are avoid, not "separate by six hours and hope."

Document the reason. The next walk-in should not restart from a title that says 2.5 mg and forgets why the last clinician walked away.

05Nine milliseconds with gatifloxacin is the additive lesson

A postmarketing study in 44 healthy volunteers gave vardenafil 10 mg, gatifloxacin 400 mg, and both. Placebo-subtracted QTcF means were about 5 msec, 4 msec, and 9 msec together. Additive. The label again says clinical impact is unknown. The operational lesson is not unknown: two QT-active drugs can add.

Gatifloxacin is not a current US community staple. The pattern still matters for other QT-active pairs. Psychiatry lists, antiemetics, and some antimicrobials belong on the same scrap of paper as the ED request.

Ritonavir and other strong CYP3A4 inhibitors raise vardenafil exposure and are exactly why 2.5 mg appears on the label - including a 72-hour spacing with ritonavir. Higher exposure is not a reason to ignore QT. It is a reason to respect both the milligram cap and the avoid list.

06Alpha-blockers and CYP3A4 caps sit beside the QT list, not instead of it

Vardenafil plus an alpha-blocker can drop standing pressure, especially when Tmax lines up. Label work with terazosin showed more trouble when doses were timed to share a peak than when peaks were separated by about six hours. A clean QT screen does not retire that counseling. Be on a stable alpha-blocker dose before anyone starts vardenafil, and start small - 5 mg is a common labeled caution start, 2.5 mg when certain CYP3A4 inhibitors are already onboard.

Ketoconazole 400 mg daily, itraconazole 400 mg, clarithromycin, and several protease inhibitors cap vardenafil at 2.5 mg in a 24-hour window on the Levitra sheet. Ritonavir is stricter: 2.5 mg in 72 hours, because half-life stretched toward 26 hours in interaction work. Those caps are why Halo locked 2.5 mg. They are not a QT waiver.

Moderate hepatic impairment needs a labeled adjustment. Severe (Child-Pugh C) is a do-not-use on Levitra. Renal impairment raised AUC modestly in moderate-to-severe groups; the QT avoid list still applies if an antiarrhythmic is the real problem.

Treadmill studies at 10 mg and 20 mg in men with stable coronary disease did not shorten exercise time versus placebo. That is not a clearance to ignore angina or nitrates. Sexual activity itself has a cardiac cost. If sex is inadvisable on cardiovascular grounds, no PDE5 onset note or QT note creates a loophole.

Write QT drugs, CYP3A4 inhibitors, and alpha-blockers on one scrap. Three partial lists are how a 2.5 mg e-script slips through. The vardenafil brief holds the full interaction grid; this note only refuses the "tiny tablet, skip the heart questions" shortcut.

If the only ECG in the chart is five years old and the patient now takes a new QT-active antidepressant, do not treat the old tracing as a lifetime pass. Re-ask the list. If the clinician wants a new ECG, that is their call. This note will not invent a QTc number that "clears" 2.5 mg.

07Ask the rhythm questions before the first small tablet

Vardenafil 2.5 mg is a real start on this domain and a real QT drug. Congenital long QT and Class IA or III antiarrhythmics are avoid. The 59-man study put 10 mg in the same millisecond neighborhood as moxifloxacin 400 mg. Additive pairs exist.

Dr. Camille Rousseau reviews Halo briefs. Electrophysiology decisions stay with the clinicians who already hold the rhythm file.

If the list is clean, you still open the onset note and the nitrate wall. A passed QT screen is permission to keep reading, not permission to skip stimulation, food, or once-daily frequency. A skipped list is how 2.5 mg becomes a false comfort. If the list is dirty, stop and write the reason before anyone offers a sample.